Reduction of Purkinje Cell Pathology in SCA1 Transgenic Mice by p53 Deletion
- 31 December 2001
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 8 (6) , 974-981
- https://doi.org/10.1006/nbdi.2001.0444
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Identification of genes that modify ataxin-1-induced neurodegenerationNature, 2000
- The function of PML in p53-dependent apoptosisNature Cell Biology, 2000
- Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 MiceNeuron, 1999
- Evidence for Proteasome Involvement in Polyglutamine Disease: Localization to Nuclear Inclusions in SCA3/MJD and Suppression of Polyglutamine Aggregation in vitroHuman Molecular Genetics, 1999
- Ubiquitin, cellular inclusions and their role in neurodegenerationTrends in Neurosciences, 1998
- Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor NeuronsNeuron, 1998
- Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1Nature Genetics, 1998
- Purkinje Cell Expression of a Mutant Allele ofSCA1in Transgenic Mice Leads to Disparate Effects on Motor Behaviors, Followed by a Progressive Cerebellar Dysfunction and Histological AlterationsJournal of Neuroscience, 1997
- SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeatCell, 1995
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992